105 related articles for article (PubMed ID: 4988640)
1. Nitroglycerine in angina.
Br Med J; 1970 Aug; 3(5717):239. PubMed ID: 4988640
[No Abstract] [Full Text] [Related]
2. [Anti-anginal action, by opposite mechanisms, of nitroglycerin and propranolol].
Giani P; Folli G; Bruno L; Binaghi G; Rizzato GF; Bandera L
Cuore Circ; 1969 Oct; 53(5):213-32. PubMed ID: 4984065
[No Abstract] [Full Text] [Related]
3. Physiologic approach to the treatment of angina pectoris.
Mason DT; Spann JF; Zelis R; Amsterdam EA
N Engl J Med; 1969 Nov; 281(22):1225-8. PubMed ID: 4981526
[No Abstract] [Full Text] [Related]
4. [Therapeutic action of nitroglycerine].
Novikova EB
Kardiologiia; 1973; 13(6):147-56. PubMed ID: 4198653
[No Abstract] [Full Text] [Related]
5. Haemodynamic effects of angina pectoris, and of nitroglycerin in normal and anginal subjects.
Hoeschen RJ; Bousvaros GA; Klassen GA; Fam WM; McGregor M
Br Heart J; 1966 Mar; 28(2):221-30. PubMed ID: 5006472
[No Abstract] [Full Text] [Related]
6. Medical management of patients with angina pectoris.
Goldstein RE; Epstein SE
Prog Cardiovasc Dis; 1972 Jan; 14(4):360-98. PubMed ID: 4400516
[No Abstract] [Full Text] [Related]
7. Perhexilene maleate in treatment of angina pectoris.
Lyon LJ; Nevins MA; Risch S; Henry S
Lancet; 1971 Jun; 1(7712):1272-4. PubMed ID: 4104721
[No Abstract] [Full Text] [Related]
8. Different effects of nitroglycerin and nitroprusside on myocardial blood flow and metabolism.
Ihlen H
Scand J Clin Lab Invest Suppl; 1984; 173():75-9. PubMed ID: 6442005
[No Abstract] [Full Text] [Related]
9. Effects of perhexiline on symptomatic and hemodynamic responses to exercise in patients with angina pectoris.
Pepne CJ; Schang SJ; Bemiller CR
Am J Cardiol; 1974 May; 33(6):806-12. PubMed ID: 4207576
[No Abstract] [Full Text] [Related]
10. Mechanism of action of beta-blocking drugs in angina pectoris: a review.
Robinson BF
Postgrad Med J; 1976; 52 Suppl 4():43-5. PubMed ID: 9630
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacologic therapy of angina pectoris].
Siepe O
Minerva Med; 1972 Apr; 63(31):1800-3. PubMed ID: 4402001
[No Abstract] [Full Text] [Related]
12. The qualitative dynamics of angina pectoris and the effect of certain drugs as recorded with the high-frequency (acceleration) direct body ballistocardiograph.
Winer NJ
Bibl Cardiol; 1973; 0(31):181-8. PubMed ID: 4213474
[No Abstract] [Full Text] [Related]
13. Medical therapy of angina pectoris.
Parmley WW
Angiology; 1977 Dec; 28(12):865-72. PubMed ID: 414639
[TBL] [Abstract][Full Text] [Related]
14. Effects of sublingually and intravenously administered nitroglycerin on the cardiovascular system of the dog.
Gillis RA; Melville KI
Am J Cardiol; 1971 Jul; 28(1):38-42. PubMed ID: 4997142
[No Abstract] [Full Text] [Related]
15. Hemodynamic factors and indirect assessment of myocardial oxygen consumption in the therapy of angina pectoris.
Asmterdam EA; Mason DT
Angiology; 1977 Dec; 28(12):844-52. PubMed ID: 23715
[No Abstract] [Full Text] [Related]
16. Drug therapy in the treatment of angina pectoris.
Kise MS
Nurs Clin North Am; 1976 Jun; 11(2):309-18. PubMed ID: 818627
[No Abstract] [Full Text] [Related]
17. [The anti-angina action of carnitine].
Cherchi A; Fonzo R; Lai C; Mercuro G; Corsi M
Boll Soc Ital Cardiol; 1978; 23(1):71-89. PubMed ID: 754784
[No Abstract] [Full Text] [Related]
18. Medical management of patients with angina. Has first-line management changed?
Chatterjee K; Rouleau JL; Parmley WW
JAMA; 1984 Sep; 252(9):1170-6. PubMed ID: 6147425
[No Abstract] [Full Text] [Related]
19. [Therapy of angina pectoris].
Atzenhofer-Baumgartner K
Wien Med Wochenschr; 1974 Nov; 124(44):631-5. PubMed ID: 4154536
[No Abstract] [Full Text] [Related]
20. A possible explanation for the absence of anti-anginal properties of transdermal nitroglycerin units: an echocardiographic study.
Bennett ED; Davis AL
Br J Clin Pharmacol; 1985 Apr; 19(4):435-40. PubMed ID: 3922393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
